You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,317 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Not yet recruiting
  • Idiopathic Subglottic Tracheal Stenosis
  • Everolimus Oral Tablet
  • (no location specified)
2022-03-31
Mar 31, 2022
G
Completed
  • Breast Cancer
  • Hormone Receptor Positive Tumor
  • 3 weeks Dose Induction of Everolimus
  • +3 more
  • Neu Isenburg, Hessen, Germany
  • +13 more
2022-02-22
Feb 22, 2022
M
Completed
  • Bladder Cancer
  • Metastatic Transitional Cell Carcinoma
  • Everolimus
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-12-16
Dec 16, 2021
N
Completed
  • Brain Tumor
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-01-07
Jan 7, 2022
Y
Terminated
  • Breast Cancer
  • Everolimus
  • New Haven, Connecticut
    Yale University
2022-01-12
Jan 12, 2022
B
Enrolling by invitation
  • Progeria
  • Everolimus and lonafarnib
  • Boston, Massachusetts
    Boston Children's Hospital
2021-06-11
Jun 11, 2021
Y
Recruiting
  • Renal Cell Carcinoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
2021-12-13
Dec 13, 2021
U
Terminated
  • Low Grade Glioma
  • +3 more
  • San Francisco, California
    University of California, San Francisco
2021-11-03
Nov 3, 2021
F
Not yet recruiting
  • Renal Cell Carcinoma
  • Anlotinib hydrochloride
  • everolimus
  • Shanghai, China
    270 Dongan Road, Fudan University Shanghai Cancer Center
2021-11-05
Nov 5, 2021
T
Active, not recruiting
  • Differentiated Thyroid Cancer
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
2021-10-18
Oct 18, 2021
E
Completed
  • Solid Organ Malignancies
  • +2 more
  • Atlanta, Georgia
  • +1 more
2021-11-19
Nov 19, 2021
U
Recruiting
  • Classical Hodgkin Lymphoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2021-07-23
Jul 23, 2021
S
Completed
  • Breast Cancer
  • Everolimus
  • +4 more
  • Guangzhou, Guangdong, China
    Sun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University
2021-09-22
Sep 22, 2021
N
Completed
  • Epilepsy
  • +2 more
  • Everolimus
  • New York, New York
    New York University Langone Medical Center
2021-08-31
Aug 31, 2021
S
Active, not recruiting
  • Glioblastoma Multiforme
  • Glioma of Brain
  • Chandler, Arizona
  • +2 more
2022-03-10
Mar 10, 2022
U
Terminated
  • Breast Neoplasms
  • +2 more
  • Baltimore, Maryland
    University of Maryland Marlene & Stewart Greenebaum Cancer Cente
2022-02-09
Feb 9, 2022
A
Active, not recruiting
  • Breast Cancer
  • Ovarian Cancer
  • Sioux Falls, South Dakota
    Avera Cancer Institute
2021-08-24
Aug 24, 2021
H
Completed
  • Kidney Transplant Infection
  • São Paulo, Sao Paulo, Brazil
    Hospital do Rim
2021-08-23
Aug 23, 2021
U
Active, not recruiting
  • Recurrent Childhood Ependymoma
  • Everolimus
  • Stanford, California
  • +3 more
2022-01-31
Jan 31, 2022
T
Suspended
  • Thyroid Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2021-10-07
Oct 7, 2021
M
Completed
  • Prostate Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-06-29
Jun 29, 2021
M
Active, not recruiting
  • Advanced Cancers
  • Solid Tumors
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-06-15
Jun 15, 2021
H
Withdrawn
  • Facial Angiofibromas
  • Everolimus
  • Placebo
  • Bron, France
    Hopital Femme Mère Enfant
2021-04-28
Apr 28, 2021